Introduction
Ribosomal S6 kinases (RSKs) are serine/threonine protein kinases activated by a wide range of mitogenic stimuli through the Mitogen-Activated Protein Kinase/ Extracellular Signal-Regulated Kinase (MAPK/ERK) signaling pathway (Chen et al., 1991) . In mammals, three highly related isoforms, RSK1, RSK2, RSK3, issued of three independent genes, have been identi®ed (Moller et al., 1994) . RSK structure is unusual in that it is composed of two complete non-identical kinase domains linked together by a regulatory region (Jones et al., 1988; Dalby et al., 1998) . The N-terminal kinase domain is responsible for phosphotransferase activity toward substrates, whereas the C-terminal kinase domain is necessary for enzymatic activation of the N-terminal kinase domain Sutherland et al., 1993; Bjorbaek et al., 1995; Fisher and Blenis, 1996) . Phorbol ester-induced activation of RSK1 is accompanied in COS-1 cells by the phosphorylation of six residues, one in each N-and C-terminal domain, three in the linker region and one at the C-terminus (Dalby et al., 1998 ). An ERKdocking site located within the C-terminal tail, which allows ERK to bind RSK, was shown to be required for activation (Smith et al., 1999; Gavin and Nebrada, 1999 ). Yet, the mechanism of coordination between the phosphorylation events upon stimulation is not fully elucidated.
RSKs have been reported to phosphorylate various substrates in vitro: S6, c-Fos, serum response factor, Nur 77, CREB and histones (Fisher and Blenis, 1996) . In vivo, CREB (Xing et al., 1996; De Cesare et al., 1998) , histone H3 , and cFos (Swanson et al., 1999) are physiological targets of RSK2, while activity of NF-kB (Schouten et al., 1997; Ghoda et al., 1997) and oestrogen receptor-mediated transcription (Joel et al., 1998) are enhanced by RSK1. Induction of RSKs has been therefore generally associated to activation of gene expression and in particular to the transcriptional induction of immediate-early genes (Blenis, 1993) . Although the substrate speci®city of each isoform, in response to a precise stimulus remains poorly understood, the importance of RSK2 was recently underlined by the ®nding that inactivating mutations in the human RSK2 gene are associated with a syndromic form of mental retardation, Con-Lowry syndrome (CLS) (Young, 1988; Trivier et al., 1996; MeÂ rienne et al., 1998; Jacquot et al., 1998) . Importantly, in cells derived from CLS patients, EGF-induced phosphorylation of CREB and H3 is drastically impaired Sassone-Corsi et al., 1999) , indicating that RSK1 and RSK3 are not able to compensate for the absence of RSK2. Further elucidation of the downstream and upstream components of the signaling cascade leading to RSK2 activation is necessary for a full understanding of the molecular basis of the CLS condition.
The MAPK-dependent signaling pathway plays a critical role in conveying the information from extracellular stimuli to gene expression. Three MAPK families have been identi®ed in mammals (Cano and Mahadevan, 1995; Karin and Hunter, 1995) . Of these, the MAPK/ERK cascade has been the most extensively studied. ERKs are strongly activated by growth factors or tumor-promoting phorbol esters and mediate cellular responses involved in cell proliferation and dierentiation (Blumer and Johnson, 1994) . In addition, at least two stress-activated protein kinase (SAPK) pathways exist, the MAPK/Jun N-terminal protein kinase (JNK) (Cano and Mahadevan, 1995; Mohit et al., 1995; Lin et al., 1995; Derijard et al., 1995) and the MAPK/p38 (Freshney et al., 1994; Han et al., 1994; Lee et al., 1994; Rouse et al., 1994) . Upon stimulation by stress-factors or in¯ammatory cytokines, activation of these pathways leads to cell death, survival or defense Xia et al., 1995; Lavoie et al., 1995) . Although the three MAPKs cascades are regulated similarly, each is activated by a distinct set of MAPK kinases leading to phosphorylation of preferential sets of substrates (Han et al., 1994; Cano and Mahadevan, 1995; Lin et al., 1995; Derijard et al., 1995) . Interestingly, cross-talks between mitogen-and stress-induced signaling pathways have been evidenced at the transcriptional level (Whitmarsh et al., 1995; Janknecht and Hunter, 1997) , at the level of dierent MAPK-activated protein kinases, and at the level of upstream components of the MAPK kinase cascades (Radler-Pohl et al., 1993; Price et al., 1996) . In particular, ERKs have been shown to be activated by stress-inducers such as arsenite (Ludwig et al., 1998) or UV irradiation (Huang et al., 1999) . Kharbandha et al. (1994) found that exposure of U-937 myeloid leukemia cells to ionizing radiation is also associated to RSK activation. However, Deak et al. (1998) observed no signi®cant activation of RSK1/2 in human embryonic kidney 293 cells exposed to UV irradiation or treated with arsenite.
In this paper, we report the eects of UV irradiation on RSK2 phosphorylation and activation in various cell lines. We have generated two novel phosphospeci®c anti-RSK2 antibodies, designed to recognize the phosphorylated forms of the N-or C-kinase domains. With the help of these antibodies, we have been able to link the phosphorylation state of the kinase with its activity upon UV-stimulation. We ®nd that UV-light induces RSK2 phosphorylation and activation, through a mechanism involving both the MAPK/MEK1 and SAPK pathways. The eect on RSK2 is not isoform-speci®c as RSK1 and RSK3 also respond to UV-treatment.
Results

Characterization of antibodies phosphospecificity
Monoclonal antibodies directed against the active form of the N-and C-terminal kinase domains of RSK2 were generated by immunization of Balb/c mice with phosphopeptides generated in vitro. The speci®city of these antibodies (indicated as P-S227 and P-T557; Figure 1a) , was tested by Westernblotting using EGF-stimulated COS-1 cells transfected with the pTL1 expression vector encoding HA-tagged wild-type and mutated RSK2 (Figure 1b,c) . Detection NKD and CKD design the N-terminal and the C-terminal kinase domains respectively. The location of the ®ve regulatory phosphorylation sites in RSK and the corresponding anti-phospho antibodies are indicated. P-365, P-369 and P-386 were previously described (Dalby et al., 1998) , and P-S277 and P-T577 are characterized in the present study. Sequences surrounding residues corresponding to Ser 227 and Thr 557 in RSK1, RSK2 and RSK3 are aligned. (b,c) Phospho-speci®city of P-S227 and P-T577. COS-1 cells transfected with either the empty expression-vector pTL1, pTL1-HA-RSK2 or pTL1-HA-S227A (b) and pTL1, pTL1-HA-RSK2 or pTL1-HA-T577A (c) constructs were serum-deprived or stimulated with EGF. Total cell lysates were analysed by Western blot using P-S227 (b) and P-T577 (c) monoclonal antibodies. P-T577 and P-S227 recognize speci®cally RSK2 phosphorylated at S227 and T577, respectively. (d) Total cell lysates from the transfected COS-1 cells were analysed with the anti-HA antibody 12CA5. (e) Kinase activity of wild-type RSK2 and T577A and S227A mutants. S6 peptide kinase assays were performed on anti-HA immunoprecipitated proteins prepared from serum-deprived or EGF-stimulated COS-1 transfected cells. Mean levels of wild-type HA-RSK2 unstimulated kinase activity were 4.6 10 4 c.p.m./10 min reaction, that is 1.2+0.1 nmol of ATP transferred/min/reaction by P-S227 and P-T577 of the 90-kDa band corresponding to HA-RSK2 was markedly increased upon stimulation with EGF. In our conditions, P-T577 detected also endogenous activated RSK, whereas P-S227 did not (Figure 1b, c) . The speci®city of the antibodies was further con®rmed by using RSK2 mutants. Mutation of Ser 227 and Thr 577 to Ala prevented recognition of HA-RSK2 by P-S227 and P-T577, respectively (Figure 1b, c) . Kinase activities of anti-HA immunoprecipitated protein extracts derived from COS-1 cells transfected with the wild-type and mutated constructs were also determined. The impaired kinase activities of mutants S227A and T577A (Figure 1e ) re¯ected their inability to be phosphorylated at residues 227 and 577, respectively. In addition, EGF-stimulated forms of mutant S227A and wild-type RSK2 were similarly phosphorylated at residue threonine 577, whereas EGF-activated form of mutant T577A was less phosphorylated than wild-type RSK2 at residue serine 227 (not shown). Altogether, these data are in agreement with previous results showing that activation of the N-terminal kinase domain depends on activation of the C-terminal kinase domain (Dalby et al., 1998; Jensen et al., 1999) .
Mitogenic and stress-factors phosphorylate and activate RSK2 in COS-1 cells
The eects of various stimuli on the phosphorylation and activation state of RSK2 in COS-1 cells transfected with pTL1-HA-RSK2 was examined. Surprisingly, UV light and sodium arsenite induced an increase in phosphorylation at all the phosphoacceptor sites to an extent comparable to that of TPA and EGF (Figure 2a ). Assessment of kinase activity showed that UV light and sodium arsenite induced a threefold activation of HA-RSK2, which is similar to EGF-induced activation ( Figure 2b ).
Concomitant phosphorylation of all RSK2 regulatory sites upon EGF and UV stimulation
Kinetics of phosphorylation of HA-RSK2 following treatment with EGF or UV light were assessed. EGF stimulation resulted in a rapid increase of RSK2 phosphorylation, within 10 min following treatment. Phosphorylation was transient as it disappeared 30 min after treatment ( Figure 2c ). In contrast, the pattern of phosphorylation and dephosphorylation associated to UV-stimulation was dierent as the increase of phosphorylation was detected within 5 min after induction and disappeared slowly, 1 to 3 h after treatment (Figure 2d ). Importantly, in both cases all sites were phosphorylated concomitantly upon stimulation, suggesting that the mechanism of RSK activation by mitogenic-and stress-factors is similar.
RSK1 and RSK3 are phosphorylated and activated in UV-treated COS-1 cells
The ability of RSK1 and RSK3 to be phosphorylated and activated by UV light was investigated in COS-1 cells transfected either with pMT2-HA-rat RSK1 or pMT2-HA-human RSK3 vectors (Zhao et al., 1996) . Interestingly, the P-T577 antibody detected the activated forms of both RSK1 and RSK3 (Figure 3a) . This was expected given the high degree of sequence identity between the three RSK isoforms, especially within the activation loop of the kinase domains. Using the P-T577 antibody an increase in phosphorylation of HA-RSK1 and HA-RSK3 upon UV treatment is observed, which is comparable to that obtained with EGFstimulated cells (Figure 3a) . These results were con®rmed as UV light induced a threefold activation of both HA-RSK1 and HA-RSK3 (Figure 3b) . Thus, all three RSKs appear to be activated by UV light in a similar extent.
Endogenous RSK2 is phosphorylated and activated upon UV treatment
The response of endogenous RSKs to UV light was analysed in various cell lines using the P-T577 antibody. UV and EGF treatment of NIH3T3, CV1 and COS-1 cells induced similar phosphorylation of RSKs (Figure 4a ). Therefore, activation of RSKs by UV light does not appear to be restricted to one cell type. Using a speci®c anti-RSK2 antibody, we detected the RSK2 proteins in the corresponding cell extracts (Figure 4a ), suggesting that endogenous RSK2 might respond to UV light. To de®ne the contribution of RSK2 isoform, we applied the same treatments to cells derived from CLS patients . The cells selected were primary ®broblasts derived from a CLS patient carrying a splice-site mutation in the gene coding for RSK2. The product resulting from this mutation lacks the entire C-terminal kinase domain, and was shown to be unstable and to have no detectable kinase activity (Trivier et al., 1996; De Cesare et al., 1998) . Therefore, the contribution of RSK2 to the pool of RSK proteins is lacking in CLS cells. In addition, the epitope recognized by the P-T577 antibody is also lacking in the RSK2 truncated CLS form. Strikingly, UV-and EGF-induced phosphorylation was strongly impaired in CLS cells (Figure 4b ). In contrast, RSK proteins from control human ®broblasts were eciently phosphorylated upon treatment with EGF and UV light (Figure 4b ). Therefore, in human ®broblast cells, endogenous RSK2 proteins are clearly phosphorylated when stimulated with UV, although EGF-induced phosphorylation is more ecient (Figure 4b ). This result was con®rmed as in human ®broblasts, proteins immunoprecipitated with an anti-RSK2 antibody revealed that UV light and sodium arsenite induced a threefold activation (Figure 4c ). In comparison, EGF induced a ®vefold activation of RSK2 kinase activity (Figure 4c) . Thus, endogenous RSK2 is phosphorylated and activated upon treatment with stress-factors in various cell lines.
Phosphorylation and activation of RSK2 by UV light involves the ERK pathway
We aimed to identify the signaling pathways involved in UV-induced RSK2 activation. For this purpose, COS-1 cells transfected with HA-RSK2 were pretreated with inhibitors of various MAPK pathways prior to UV stimulation. Kinase activities of the corresponding anti-HA immunoprecipitated protein extracts were then determined. Using the speci®c MEK1 inhibitor, PD 98059, we found that activation of RSK2 by UV light is blocked (Figure 5a ). Western blot analysis con®rmed that UV-induced phosphorylation of T577 was inhibited by treatment with PD 98059 (Figure 5b ). Similar results were obtained when treating cells with PD 98059 prior to EGF stimulation (Figure 5a,b) , suggesting that UV treatment results in the activation of the MAPK/ERK pathway in COS-1 cells. Moreover, ERKs were activated signi®cantly by UV light, as revealed with a speci®c P-ERK antibody directed against active ERK1 and ERK2 (Figure 5b ). PD 98059 inhibited phosphorylation of ERK proteins mediated by both EGF and UV light (Figure 5b ). However, as described by Alessi et al. (1995) , activation of ERKs and RSK2 following stimulation with EGF at 100 ng/ml was C.
D. (Deak et al., 1998) . Therefore, we wished to investigate the possible role of the SAPK2/p38 signaling pathway in activation of RSK2 by UV light. We pretreated UV-stimulated COS-1 cells, transfected with the HA-RSK2 construct, with various concentrations of the SAPK2/p38 speci®c inhibitor, SB 203580. Interestingly, we observed a signi®cant inhibition of activation and phosphorylation of RSK2 (Figure 5a,b) , which was not seen in EGF-treated cells. In addition, treatment with both PD 98059 and SB 203580 has an additive eect (Figure 5a ). These data indicate that the SAPK2/p38 kinase also contributes to the activation of RSK2 by UV light in COS-1 cells.
Phosphorylation and activation of RSK2 by UV light is mediated by the ERK pathway in human fibroblasts
In order to establish the contribution of the ERK pathway in RSK2 phosphorylation in response to stress, we pretreated human ®broblasts with PD 98059 or/and SB 203580 prior to stimulation. PD 98059 inhibited activation and phosphorylation of endogenous RSK2 induced by EGF and by UV light (Figure  6a 6a,b). In addition, the levels of inhibition of RSK2 kinase activity we obtained by treating the ®broblasts with PD 98059 alone or with both PD 98059 and SB 203580 were equivalent (Figure 6a) . Thus, it appears that the activation of RSK2 by UV light in human ®broblasts is mainly mediated by the MAPK/ERK pathway.
Activation of RSK2 by UV light requires its carboxyl-terminal tail
The above results suggest that the mechanisms of activation of RSK upon UV-and EGF-treatment are similar. To further con®rm this hypothesis, we generated a mutant of RSK2 lacking the C-terminal eleven amino acids of the protein. Activation of RSK by mitogenic factors requires this carboxyl-terminal tail, which contains an ERK-docking site (Smith et al., 1999) . Binding of ERK2 to this site is necessary for ecient phosphorylation and activation of RSK in vitro and in vivo (Zhao et al., 1996; Smith et al., 1999) . COS-1 cells were transfected with a construct encoding RSK2 deleted from its C-terminal tail (D-C-ter) prior to stimulation. Both EGF and UV light had almost no eect on D-C-ter kinase activation and residue threonine 577 phosphorylation (not shown), demonstrating that UV-dependent activity of RSK2, as for EGF requires its carboxyl-terminal tail, and presumably the ERK-docking site.
Discussion
We have generated two monoclonal antibodies that recognize two phosphorylated sites, P-Ser227 and PThr577, in the N-and C-terminal kinase domains of RSK2, respectively. As expected from the high degree of sequence identity between the three RSK isoforms, both antibodies reveal the phosphorylated forms of all three RSK members. To further characterize the antibodies, we have used them in addition to three other previously described (P-T364, P-S369 and P-S386) (Dalby et al., 1998) , to establish phosphorylation kinetics of these sites upon EGF stimulation (Figure 2) . Previous studies have shown that in TPA-induced RSK1, two sites are basally phosphorylated, and four upon mitogen stimulation (Dalby et al., 1998) . Recent results indicate that EGF activates RSK2 by a mechanism similar to the one described for PMA activation of RSK1 (Jensen et al., 1999) . As a probable sequence of events, ERK phosphorylates Ser369 in the linker region and Thr577 in the C-terminal kinase domain, leading to activation of the latter. The Cterminal domain then phosphorylates an additional site Total cell extracts were analysed by Western blot using P-T577, 12CA5 and anti-P-ERK antibodies Figure 6 UV-induced phosphorylation and activation of endogenous RSK2 from normal human ®broblasts is inhibited by PD 98059. (a) Kinase activities on immunoprecipitated RSK2 derived from human ®broblasts, treated as in Figure 5a . (b) Western blot analysis on total protein extracts prepared as in Figure 5b , except that to control the protein level of RSK2, the anti-RSK2 was used instead of the 12CA5 antibody in the linker region, Ser386. Dual phosphorylation of the linker region leads to increased phosphorylation of Ser227 in the N-terminal domain, resulting in phosphotransferase activity towards exogenous substrates. However, ERK mediated phosphorylation and activation of the N-terminal kinase domain requires a prior basal level of phosphorylation of Ser227 by 3-phosphoinositide-dependent protein kinase-1 (PDK1), suggesting that the role of the two ERK-induced phosphorylation in the linker region is to enhance activation of the N-terminal kinase domain by PDK1 (Jensen et al., 1999; Richards et al., 1999) . Our results using the combination of ®ve phospho-speci®c monoclonal antibodies are consistent with this scenario and con®rm that phosphorylation of all these sites occurs in concert in response to a mitogenic stimulus, resulting into concomitant activation of the kinase. Our newly generated antibodies will constitute powerful tools to understand how the N-and C-kinase domains cooperate to coordinate these phosphorylation events and to determine the regulatory role of PDK1. MSKs share essential structural features with RSKs, i.e. two nonidentical kinase domains, suggesting a common ancestor (Deak et al., 1998; Pierrat et al., 1998; New et al., 1999) . The major functional dierence described between RSKs and MSKs, is the capacity of MSKs to be activated also by stress factors. Stimulation of MSKs by mitogens is mediated by the ERK pathway, whereas the p38 pathway is implicated in the stress-induced response (Deak et al., 1998) . In the present study we demonstrate that RSKs are also phosphorylated and activated by stress factors, and to an extent which is comparable to the EGF-mediated activation. By using speci®c inhibitors we provide evidence that phosphorylation of RSK2 in response to the UV stimulus involves a contribution of both p38 and MAPK/ERK pathways. Our results indicate that the MAPK/ERK pathway may play a prominent role in RSK2 responsiveness to the UV stimulus. Therefore, mechanisms leading to UV-induced RSK and MSK activation could be dierent, or maybe follow strict rules of cell-speci®city.
The ®nding that RSKs are activated in vivo by both mitogens and stress implies that they play a role in integrating the eect of dierent extracellular signals. Some RSK substrates are therefore likely to become phosphorylated and activated in response to either mitogenic or stress signals. Such substrates may include the transcription factors CREB, c-Fos and the nuclear factor kappa-B (NF-kB), and histone H3. Upon mitogenic stimulation RSK2 phosphorylates CREB at Ser133, the activating site that becomes also phosphorylated in vivo in response to stress signals (Xing et al., 1996; Tan et al., 1996; De Cesare et al., 1998) . RSKs have been implicated in c-fos induction via phosphorylation of the Serum Response Factor (SRF) (Rivera et al., 1993; Karin, 1995) , and there is also some evidence that c-Fos is directly phosphorylated by RSK2 Swanson et al., 1999) . We have further con®rmed that EGF-induced expression of c-fos is drastically downregulated in human ®broblasts bearing a non-functional RSK2 . Importantly, previous results have indicated that ERKs are required for full UV responsiveness of c-Fos (Price et al., 1996) and CREB (Iordanov et al., 1997) . Mitogen induced activation of the transcription factor NF-kB, a key regulator of genes involved in growth control and apoptosis (Liu et al., 1996; Wu et al., 1996) has been shown to be mediated by RSKs (Schouten et al., 1997) . We have demonstrated that RSK2 is required for EGF-induced phosphorylation of histone H3 . Histone H3 phosphorylation may be associated with a relaxed state of transcriptionally active chromatin coincident with the mitogenic induction of early-response genes, as well as make chromatin accessible to nucleases involved in apoptotic pathways (Waring et al., 1997) .
It will be important to investigate the role of the ERK/RSK pathway in the stress-induced phosphorylation and activity of these substrates. Targeted deletion of RSK genes in the mouse could help to answer some of these questions, but the issue of redundancy between related RSK proteins would have to be addressed.
Materials and methods
Reagents
EGF, 12-0-tetradecanoylphorbol 13-acetate (TPA) and sodium arsenite were from Sigma, and PD 98059 and SB 203580 from Calbiochem. Anti-RSK antibodies were from Santa Cruz Biotechnology, anti-HA antibody (12CA5) from Boehringer-Mannheim and anti-phospho ERKs antibody from New England Biolabs. Anti-phospho T365, S369 and S386 RSK2 antibodies were from Upstate Biotechnology.
Anti-phospho S227 and T577 RSK2 monoclonal antibodies production Anti-phospho S227 (P-S227) and anti-phospho T577 (P-T577) antibodies were generated by immunizing mice with the following synthetic phosphopeptides coupled to ovalbumine: EKKAYS*FCGTVEYMAPE (residues 222 ± 238 of RSK2) and KQLRAENGLLMT*PCYTAN (residues 563 ± 580 of RSK2), respectively. Spleen cells were isolated and fused with myeloma cells. Culture supernatants were screened using dierential ELISA in which the phosphopeptide, the corresponding nonphosphopeptide and an irrelevant phosphopeptide were employed. Positive supernatants were tested by Western blot analysis on EGF-stimulated transfected COS cell extracts, using the constructs described below. Speci®c hybridomas were cloned twice on soft agar. For ascite¯uid production, two 10 6 cells were injected in pristane primed BALB/c mice.
Construction of RSK2 mutant expression vectors
A pTL1-based cDNA encoding an amino-terminal HAtagged RSK2 protein was previously described (MeÂ rienne et al., 1999) . Site-speci®c mutants RSK2 S227A, and T577A were generated by standard methods and sequenced.
Cell culture, stimulation, and lysis Human control and CLS ®broblasts, NIH3T3, CV1, and COS-1 cells were cultured to con¯uence on plates, in DMEM with 10% fetal calf serum. Cells were serum-starved by an additional 24-h incubation with DMEM, incubated with 50 mM PD 98059 and/or 10 mM SB 203580 for 1 h and stimulated with either EGF 100 ng/ml for 10 min, or TPA 200 ng/ml for 15 min, or sodium arsenite 0.5 mM for 20 min. Cells submitted to UV light were irradiated for 10 s and harvested 30 min after treatment. Cells were washed once with ice-cold phosphate-buered saline (PBS) and resuspended in 500 ml cold lysis buer (Trivier et al., 1996) . After 10 min on ice, cells were disrupted by repeated aspiration through a 20-gauge needle and lysates centrifuged at 13 000 g for 15 min at 48C.
Western analysis
Cell lysates were resolved by standard SDS/10% PAGE. Samples were electroblotted onto Protan nitrocellulose (Schleicher and Schuell). Membranes were incubated in TBS/1% low-fat milk overnight at 48C with speci®c antibodies. Immunocomplexes were revealed by chemiluminescence with anti-mouse, -rabbit or -goat-HRP antibodies.
Immunoprecipitation and kinase assay
Equal amounts of total proteins were incubated with anti-RSK2 antibody for 2 h at 48C, and then with protein Gsepharose for 30 min. Immunoprecipitates were washed three times in lysis buer and once in kinase assay buer (Trivier et al., 1996) . Kinase reactions were performed using the S6 kinase assay kit (Upstate Biotechnology).
Transfection COS-1 cells were transfected by the calcium phosphate method. After transfection (24 h), cells were serum-starved for 48 h, treated with MAPK inhibitors and stimulated as described above. Cells were then washed in PBS and lysed in 500 ml lysis buer. HA-tagged RSK2 protein were immunoprecipitated overnight at 48C using antibody 12CA5 (1 : 250). Immune complexes were allowed to react with protein Asepharose beads for 30 min at 48C.
